Reflections on treating a patient with cognitive differences
The patient was unable to accept blood transfusions, and his cognitive differences prevented him from understanding the course of his leukemia as it progressed. Mikkael Sekeres, MD, MS, writes about what it was like to care for a patient with a loving family, limited treatment options and cognitive differences in the solitary times of COVID-19 in this New York Times column.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
“At the end, he didn’t suffer much. And as a parent, I can’t say for certain that I would have the strength to care for a dying child at home,” Dr. Sekeres writes. “But I also can’t be certain if it was right to preserve his hope until he passed, while leaving him unprepared for a solitary death; perhaps unaware of what was occurring, but perhaps aware.”
Dr. Sekeres is Director of Cleveland Clinic Cancer Center’s Leukemia Program. You can follow him on Twitter @MikkaelSekeres.
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust